Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Email

Gastrointestinal Steering Committee Roster

The Gastrointestinal Steering Committee (GISC) addresses the design, prioritization, and evaluation of concepts for phase 2, 2/3, and 3 clinical trials in adult gastrointestinal cancers. Committee activities help foster collaboration between groups and institutions engaged in conducting trials. The GISC's membership comprises NCTN group representatives, community oncologists, Specialized Programs of Research Excellence (SPORE) representatives, biostatisticians, patient advocates, subject matter experts, and NCI staff.

 

Co-chairs

Cathy Eng, M.D., FACP
Vanderbilt University Ingram Cancer Center
Nashville, TN

Karyn A. Goodman, M.D., M.S.
Tisch Cancer Institute at Mount Sinai Hospital
New York, NY

 

Members

Carmen Allegra, M.D.
National Cancer Institute
Bethesda, MD

Rebecca Auer, M.D., M.Sc., FRCSC
The Ottawa Hospital Research Institute
Ottawa, ON, Canada

Jordan Berlin, M.D., Ph.D.
Vanderbilt University Ingram Cancer Center
Nashville, TN

Jonathan Bleeker, M.D.
University of South Dakota Medical Center
Sioux Falls, SD

Yun Shin Chun, M.D.
University of Texas MD Anderson Cancer Center
Houston, TX

Ryan B. Corcoran, M.D., Ph.D.
Massachusetts General Hospital Cancer Center
Boston, MA

Anjelica Q. Davis
Fight Colorectal Cancer
Springfield, MO

Thomas J. George, Jr., M.D., FACP
University of Florida
Gainesville, FL

Sharlene Gill, M.D., M.P.H.
University of British Columbia
Vancouver, BC, Canada

Katherine Guthrie, Ph.D., M.S.
Fred Hutchinson Cancer Research Center
Seattle, WA

Theodore S. Hong, M.D.
Massachusetts General Hospital
Boston, MA

Lisa A. Kachnic, M.D.
Columbia University Irving Medical Center 
New York, NY

Hagen F. Kennecke, M.D., M.H.A., FRCPC
Providence Cancer Institute Franz Clinic
Portland, OR

Elise Kohn, M.D.
National Cancer Institute
Bethesda, MD

Andrew Lowy, M.D., FACS
University of California San Diego Moores Cancer Center
San Diego, CA

Harvey J. Mamon, M.D., Ph.D.
Brigham and Women's Hospital
Boston, MA

Jeffrey Meyerhardt, M.D., M.P.H.
Dana-Farber Cancer Institute
Boston, MA

Margaret M. Mooney, M.D., M.B.A.
National Cancer Institute
Bethesda, MD

Donna Niedzwiecki, Ph.D.
Duke University Medical Center
Durham, NC

Christopher O'Callaghan, Ph.D., D.V.M.
Queen's University
Kingston, ON, Canada

Eileen O'Reilly, M.D.
Memorial Sloan Kettering Cancer Center
New York, NY

Philip Philip, M.D., Ph.D., FRCP
Karmanos Cancer Institute
Detroit, MI

Laura Porter, M.D., FASCO
Patient Advocate
Cheverly, MD

Lewis R. Roberts, M.B., CH.B., Ph.D.  
Mayo Clinic
Rochester, MN

Lawrence V. Rubinstein, Ph.D.
National Cancer Institute
Bethesda, MD

Qian Shi, Ph.D.  
Mayo Clinic
Rochester, MN

Terence Z. Wong, M.D., Ph.D.
Duke University Medical Center
Durham, NC

Gregory Yothers, Ph.D.
University of Pittsburgh
Pittsburgh, PA

NCI CCCT Program Director 

Laurie Shuman Moss, Ph.D.
laurie.shumanmoss@nih.gov  

 

  • Updated:
Email